PEDRON, Serena
 Distribuzione geografica
Continente #
EU - Europa 1.730
NA - Nord America 1.620
AS - Asia 795
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
OC - Oceania 1
Totale 4.167
Nazione #
US - Stati Uniti d'America 1.614
GB - Regno Unito 620
CN - Cina 507
IT - Italia 268
SE - Svezia 199
SG - Singapore 193
IE - Irlanda 133
FR - Francia 124
RU - Federazione Russa 113
DE - Germania 111
FI - Finlandia 91
BE - Belgio 25
UA - Ucraina 24
TR - Turchia 18
KR - Corea 17
VN - Vietnam 14
IN - India 9
JP - Giappone 7
TG - Togo 7
ID - Indonesia 6
NL - Olanda 6
CA - Canada 4
IL - Israele 4
IR - Iran 4
EU - Europa 3
PH - Filippine 3
AL - Albania 2
AM - Armenia 2
AT - Austria 2
AZ - Azerbaigian 2
CM - Camerun 2
EG - Egitto 2
ES - Italia 2
HK - Hong Kong 2
HR - Croazia 2
KG - Kirghizistan 2
LV - Lettonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MY - Malesia 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
Totale 4.167
Città #
Southend 579
Chandler 328
Singapore 168
Jacksonville 157
Ann Arbor 151
Woodbridge 133
Dublin 131
Ashburn 101
Beijing 96
Houston 81
Verona 77
New York 50
Wilmington 47
Jinan 45
Lawrence 44
Princeton 44
Nanjing 41
Shenyang 38
Helsinki 37
Redmond 34
Tianjin 27
Brussels 25
Sindelfingen 21
Milan 19
Zhengzhou 18
Hebei 17
Ningbo 17
Seoul 17
Dearborn 16
Guangzhou 15
Haikou 15
Changsha 14
Hangzhou 14
Lancaster 14
Nanchang 13
Taizhou 13
Düsseldorf 12
Santa Clara 11
Boardman 10
Redwood City 10
Dong Ket 9
Florence 9
Jiaxing 9
Seattle 9
Brescia 8
Dallas 8
Fairfield 8
Munich 8
San Francisco 8
Bologna 7
Lomé 7
Chions 6
Taiyuan 6
Washington 6
Augusta 5
Catania 5
Falls Church 5
Jakarta 5
Kent 5
Moscow 5
Tokyo 5
Bergamo 4
Fuzhou 4
Rome 4
Amsterdam 3
Kochi 3
Lonigo 3
Los Angeles 3
Norwalk 3
Phoenix 3
Pozza 3
Shanghai 3
Baku 2
Bishkek 2
Bitonto 2
Boydton 2
Cairo 2
Castelnuovo Rangone 2
Edinburgh 2
Hefei 2
Lanzhou 2
Las Vegas 2
Latina 2
London 2
Madrid 2
Markham 2
Naples 2
Qingdao 2
Riga 2
San Mateo 2
Toronto 2
Vienna 2
Yerevan 2
Zagreb 2
Zanjan 2
Ashgabat 1
Auburn Hills 1
Austin 1
Bratislava 1
Buenos Aires 1
Totale 2.930
Nome #
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 168
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 153
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 148
Espressione di marcatori di migrazione e invasività nei foci fibroblastici nella fibrosi polmonare idiopatica 137
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 131
Linfoma splenico a "cellule della zona marginale": studio dell'espressione di TCL1 e t-bet 128
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 125
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 112
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 111
S100P expression in cholangiocarcinoma 110
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 110
Genomic characterization of hepatoid tumors: context matters 110
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 108
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 105
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis 104
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 103
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 103
The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study 99
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 97
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 96
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 95
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 94
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours 91
CATHEPSIN-K IS A SENSITIVE IMMUNOHISTOCHEMICAL MARKER FOR DETECTION OF MICRO-GRANULOMAS IN HYPERSENSITIVITY PNEUMONITIS 90
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 88
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 88
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 86
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 83
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 82
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 82
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 80
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis 79
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology 78
ANALISI DEL DNA MEDIANTE FLUORESCENT IN SITU HYBRIDIZATION (FISH) PER L’IDENTIFICAZIONE DI ERRORI DI SCAMBIO DI TESSUTI DOPO PROCEDURE CHIRURGICHE: APPLICAZIONI NELLA PRATICA CLINICA ED IMPLICAZIONI MEDICO LEGALI 74
TCL1 and CD11c expression in hairy-cell leukemia and their diagnostic role on bone marrow biopsies in the differential diagnosis with splenic marginal zone lymphoma 70
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 62
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 61
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 53
VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations 52
High performance of multiplex fluorescence in situ hybridization to simultaneous detection of BCL2 and BCL6 rearrangements: useful application in the characterization of DLBCLs 51
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 46
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 45
The Immunohistochemical Loss of H3K27me3 in Intracranial Meningiomas Predicts Shorter Progression-Free Survival after Stereotactic Radiosurgery 45
pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells 43
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 40
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 34
Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or proliferative molecular groups show high mitotic index, chromosomal instability, and higher recurrence risk 28
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma 27
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 27
Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma 23
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 10
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 10
Totale 4.275
Categoria #
all - tutte 14.812
article - articoli 12.269
book - libri 0
conference - conferenze 2.543
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020342 0 0 0 0 46 56 49 25 26 54 36 50
2020/2021457 43 69 26 47 47 60 22 20 21 31 50 21
2021/2022501 49 125 26 58 30 18 12 33 16 16 30 88
2022/2023931 58 115 85 161 77 224 7 50 103 8 28 15
2023/2024513 24 37 40 59 76 102 16 23 4 34 83 15
2024/2025458 58 72 85 193 50 0 0 0 0 0 0 0
Totale 4.275